West Paces Advisors Inc. Eli Lilly & CO Transaction History
West Paces Advisors Inc.
- $439 Billion
- Q1 2025
A detailed history of West Paces Advisors Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, West Paces Advisors Inc. holds 2,656 shares of LLY stock, worth $2.23 Million. This represents 0.5% of its overall portfolio holdings.
Number of Shares
2,656
Previous 2,601
2.11%
Holding current value
$2.23 Million
Previous $2.01 Billion
9.25%
% of portfolio
0.5%
Previous 0.49%
Shares
30 transactions
Others Institutions Holding LLY
# of Institutions
4,314Shares Held
758MCall Options Held
10.2MPut Options Held
11.4M-
Lilly Endowment Inc Indianapolis, IN96MShares$80.7 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA74.2MShares$62.4 Billion1.03% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$55.3 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.3MShares$43.1 Billion26.72% of portfolio
-
State Street Corp Boston, MA34.3MShares$28.8 Billion1.07% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $798B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...